← Back to Search

Access to colonoscopy web app for Colon Polyps

N/A

Waitlist Available

Led By Harminder Singh, MD

Research Sponsored by University of Manitoba

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

For patient participants: Patients must be older than 50 years and up to 75 years old for inclusion in the study data. Adequate bowel preparation defined by Boston Bowel Preparation Scale Score of ≥ 2 in each of segments of the colon (Boston bowel prep scale score recording is mandatory in the Winnipeg city-wide endoscopy reporting system); Colonoscopy completed to the cecum/ileocolonic anastomosis; Colonoscopy performed between 1 to 4 months before randomization of endoscopy physician (to determine baseline adherence) or between 3 to 7 months after randomization (to determine effect of the intervention).

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 months

Awards & highlights

Study Summary

This trial is studying a tool to help optimize timing of surveillance colonoscopies for people at high risk of developing colorectal cancer.

Who is the study for?

This trial is for physicians in Winnipeg who perform colonoscopies and their patients aged 50-75 with a good bowel prep score. Patients must have had a complete colonoscopy recently. Physicians involved in the study's design or those absent for long periods post-randomization are excluded, as are patients with inherited CRC predisposition, inflammatory bowel disease, partially excised polyps, or other conditions precluding future colonoscopies.Check my eligibility

What is being tested?

The trial tests whether a smartphone app can help doctors better adhere to recommended follow-up times for surveillance colonoscopies based on patient risk factors like family history and polyp characteristics. It's a pilot randomized trial aiming to gather data for planning a larger study on the app's effectiveness in clinical practice.See study design

What are the potential side effects?

Since this intervention involves access to an informational web application rather than medication or invasive procedures, traditional physical side effects are not applicable. However, there may be indirect effects related to data privacy concerns or potential misguidance if the app malfunctions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 50 and 75 years old and had a well-prepared colonoscopy recently.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of cases where the colonoscopy physician recommendations matched with the guideline recommendation

Secondary outcome measures

Physicians' use of the application (ease of use)

Physicians' use of the application (how familiar is the information in the tool)

Physicians' use of the application (how often used during endoscopy slate)

+8 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Access to colonoscopy web appExperimental Treatment1 Intervention

Approximately half of the consenting individual endoscopy physicians in the city (gastroenterologists and surgeons) will be randomized (stratified by physician specialty) to the intervention group where they are provided access to an application which indicates recommended timing of follow-up colonoscopy given values for various entered factors. In the intervention group, the application can be downloaded to smart phones for portability which will allow access in an endoscopy suite or in clinic or used as a reference at other times. It can also be accessed online (all endoscopy rooms in Winnipeg have computers with internet access for the endoscopy physicians' use). Access to the application will be password-protected, thereby avoiding exposure of the non-intervention group to the application. The clusters of patients will be defined by the endoscopy physician providing the colonoscopy.

Group II: ControlActive Control1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor

594 Previous Clinical Trials

199,412 Total Patients Enrolled

Harminder Singh, MDPrincipal InvestigatorUniversity of Manitoba

Media Library

Access to colonoscopy web app Clinical Trial Eligibility Overview. Trial Name: NCT04889352 — N/A

Colorectal Adenomas Research Study Groups: Access to colonoscopy web app, Control

Colorectal Adenomas Clinical Trial 2023: Access to colonoscopy web app Highlights & Side Effects. Trial Name: NCT04889352 — N/A

Access to colonoscopy web app 2023 Treatment Timeline for Medical Study. Trial Name: NCT04889352 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies left to participate in this trial?

"According to clinicaltrials.gov, the trial has ended its recruitment phase; it first appeared on July 15th 2021 and was last edited December 2nd 2022. Unfortunately, this study is not taking new participants at present; however 687 other trials are still actively recruiting patients."

Answered by AI

How can I become part of this research endeavor?

"This clinical trial is recruiting 30 participants aged between 50 and 75, who have been diagnosed with polyps. In addition to the age stipulation, potential participants must also adhere to Bowel Preparation Scale Score of 2 or higher in each section of their colon (Boston bowel prep scale score recording is mandatory); they must be available for a colonoscopy that's completed at least 1 month prior to randomization; and if they are physicians, there will not be any age restrictions noted as this study hopes to introduce an information tool intended to improve patient care during colonization. Records will remain anonymous throughout the process."

Answered by AI